Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.48 |
| ▸ | CDC25A | P30304 | 3/20 | 0.43 |
| ▸ | CDC25B | P30305 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 5/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15944061 | 0.89 | CDC25A (0.52) | IDO1CDC25ACDC25BMAPTTDP1 | |
| Aurantiogliocladin SCHEMBL487583 | 0.77 | MAPT (0.50) | IDO1CDC25ACDC25BMAPTTDP1 | |
| SCHEMBL8368999 | 0.77 | IDO1 (0.44) | IDO1CDC25ACDC25BMAPTTDP1 | |
| SCHEMBL5589809 | 0.75 | CDC25A (0.44) | IDO1CDC25ACDC25BMAPTTDP1 | |
| SCHEMBL22882763 | 0.75 | IDO1 (0.44) | IDO1CDC25ACDC25BMAPTTDP1 | |
| SCHEMBL20193227 | 0.75 | APEX1 (0.42) | IDO1CDC25ACDC25BMAPTTDP1 | |
| SCHEMBL5455307 | 0.72 | CDC25A (0.48) | IDO1CDC25ACDC25BMAPTTDP1 | |
| SCHEMBL12957817 | 0.72 | MAOA (0.32) | CDC25ACDC25BMAOA | |
| SCHEMBL5590100 | 0.72 | CDC25A (0.32) | CDC25ACDC25B | |
| SCHEMBL9655485 | 0.72 | CDC25A (0.64) | IDO1CDC25ACDC25BMAPTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11541120-B2 | Phosphonium-based ionic drug conjugates | ANTHOS PARTNERS, LP (US) | 2023-01-03 | — | — | US | disclosed |
| US-20200353087-A1 | PHOSPHONIUM-BASED IONIC DRUG CONJUGATES | ANTHOS PARTNERS, LP | 2020-11-12 | — | — | US | disclosed |
| US-9801922-B2 | Compositions and methods of treating cancer | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2017-10-31 | — | — | US | disclosed |
| US-20170189447-A1 | FORMULATION FOR INCREASING ENERGY | NIS Clinical Research (US) | 2017-07-06 | — | — | US | disclosed |
| US-7601877-B2 | Condensation of a prenol or isoprenol with a hydroquinone or derivative in the presence of 0.005-1.0 mol percent of a Bronsted or Lewis acid catalyst selected from a bismuth, indium or Group 3 chloride, a heteropolyacid, and an NH- or a CH-acidic compound, oxidizing the ubihydroquinone; improved kinetics | DSM IP ASSETS B.V. (NL) | 2009-10-13 | — | — | US | disclosed |
| US-20080275275-A1 | Process for the Preparation of Ubihydroquinones and Ubiquinones | DSM IPASSETS B.V. (NL) | 2008-11-06 | — | — | US | disclosed |
| WO-2007017168-A1 | PROCESS FOR THE PREPARATION OF UBIHYDROQUINONES AND UBIQUINONES | DSM IP ASSETS B.V. (NL) | 2007-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200353087-A1 | PHOSPHONIUM-BASED IONIC DRUG CONJUGATES | SLC8B1, PHOSPHO1, PBDC1 | IDO1 3900/4885CDC25A 3230/4885CDC25B 3503/4885 |
| US-20170189447-A1 | FORMULATION FOR INCREASING ENERGY | COQ8A, COQ8B, NDUFS6 | IDO1 1952/4885CDC25A 822/4885CDC25B 792/4885 |
| US-20080275275-A1 | Process for the Preparation of Ubihydroquinones and Ubiquinones | UBE2D3, UBE2L3, UBE2I | IDO1 3306/4885CDC25A 1584/4885CDC25B 2012/4885 |
| US-11541120-B2 | Phosphonium-based ionic drug conjugates | SLC8B1, PHOSPHO1, PBDC1 | IDO1 3900/4885CDC25A 3230/4885CDC25B 3503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.